Previous data have indicated that T-type calcium channels (low-voltage activated T-channels) are potently inhibited by volatile anesthetics. Although the interactions of T-channels with a number of anesthetics have been described, the mechanisms by which these agents modulate channel activity, and the functional consequences of such interactions, are not well studied. Here, we used patch-clamp recordings to explore the actions of a prototypical volatile anesthetic, isoflurane (Iso), on recombinant human Ca V 3.1 and Ca V 3.2 isoforms of T-channels. We also performed behavioral testing of anesthetic endpoints in mice lacking Ca V 3.2. Iso applied at resting channel states blocked current through both isoforms in a similar manner at clinically relevant concentrations (1 minimum alveolar concentration, MAC). Inhibition was more prominent at depolarized membrane potentials (Ϫ65 versus Ϫ100 mV) as evidenced by hyperpolarizing shifts in channel availability curves and a 2.5-fold decrease in IC 50 values. Iso slowed recovery from inactivation and enhanced deactivation in both Ca V 3.1 and Ca V 3.2 in a comparable manner but caused a depolarizing shift in activation curves and greater use-dependent block of Ca V 3.2 channels. In behavioral tests, Ca V 3.2 knockout (KO) mice showed significantly decreased MAC in comparison with wild-type (WT) litter mates. KO and WT mice did not differ in loss of righting reflex, but mutant mice displayed a delayed onset of anesthetic induction. We conclude that state-dependent inhibition of T-channel isoforms in the central and peripheral nervous systems may contribute to isoflurane's important clinical effects.
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The effects of general anesthetics on ion channels have been the subject of intense research since studies describing specific interactions between anesthetics and proteins (Franks and Lieb, 1982, 1994) . It is now known that some ligand-gated channels (e.g., GABA A ), voltage-gated channels, and background potassium channels display anesthetic sensitivity in vitro that is within the concentration range achieved during general anesthesia (Franks, 2008) . These channels have overlapping physiological roles and pharmacological profiles, making it difficult to assign aspects of the anesthetic state to individual channel types. Thus, it has become clear that further study of anesthetic mechanisms of action on specific ion channels is needed.
Low voltage-activated calcium channels activate with small depolarizations and allow calcium influx at resting potentials so that small differences in channel activity can result in large changes in cellular excitability and/or secondmessenger pathways. Recent molecular studies have indicated that at least three isoforms of T-channels exist: Ca V 3.1 (␣1G), Ca V 3.2 (␣1H), and Ca V 3.3 (␣1I) (Perez-Reyes, 2003) . These channels are located throughout the spinothalamic pathway, in which nociceptive information passes from peripheral sensory neurons to the cortex. T-channels in smallsized dorsal root ganglia (DRG) neurons are believed to function in pain signaling (Todorovic and Lingle, 1998; Todorovic et al., 2001) . Small and medium DRG neurons contain both Ca V 3.1 and Ca V 3.2 channels, although Ca V 3.2 predominates (Talley et al., 1999) . Ca V 3.2-null mice have significantly decreased responses to acute somatic and visceral pain (Choi et al., 2007) . Furthermore, oligonucleotide antisense studies against Ca V 3.2 reported similar results (Bourinet et al., 2005) . This evidence makes it clear that T-channels are pronociceptive in the DRG.
In vivo studies have shown that anesthetic-induced loss of movement in response to pain is mediated primarily in the spinal cord. Actions in the brain are not apparently critical to inhibit motor responses to pain. This has been demonstrated in anesthetized rats, in which cervical transection of the spinal cord did not change the MAC for painful limb stimulation (Rampil, 1994) . Furthermore, in situ studies have indicated that all three isoforms of T-channels are expressed predominantly in the dorsal horn of the spinal cord, an important pain processing region of CNS (Talley et al., 1999) . Thus it is likely that any contributions of T-channels in the spinal cord to MAC of general anesthetics are indirect, because the effects would be on nociceptive pathways rather than on motor pathways in the spinal cord.
T-channels are also expressed in various brain regions and are particularly abundant in thalamic nuclei, where they are crucial for control of the functional states of those neurons (McCormick and Bal, 1997; Steriade, 2005) . In particular, Ca V 3.1 is mainly expressed in thalamocortical relay neurons, whereas Ca V 3.2 and Ca V 3.3 are expressed in thalamic reticular neurons, the main inhibitory structure in the thalamus (Talley et al., 1999) . Inhibition of thalamic processing of sensory information has been implicated recently as a possible contributor to clinical effects of anesthetics such as loss of consciousness and sedation (Alkire et al., 2000; Rudolph and Antkowiak, 2004; Franks, 2008) . Therefore, the potential of T-channel isoforms expressed in the thalamus, spinal cord, and DRG as targets for the action of general anesthetics remains an important issue in our understanding of the cellular mechanisms of anesthetic action.
It has been shown previously that Iso at clinically relevant concentrations inhibits recombinant and native T-current variants in peripheral and central neurons (Study, 1994; Todorovic and Lingle, 1998; Ries and Puil, 1999; Todorovic et al., 2000; Joksovic et al., 2005a,b) . Here, we studied the effects of clinically relevant concentrations of Iso on two kinetically similar isoforms of T-channels, Ca V 3.1 and Ca V 3.2, which are abundantly expressed in the thalamus, spinal cord, and DRG. By expressing T-type channels in a heterologous system, we are able to study individual isoforms without interference from other ionic conductances. Because it is known that Iso inhibits native T-channels, we now strive to describe the similarities and differences of its effects on each isoform and to compare in vivo effects of Iso on anesthetic endpoints in mice lacking these channels. This may lead to a better understanding of the distinct roles of these channels in anesthesia.
Materials and Methods
Human Embryonic Kidney-293 Cells. For recordings of recombinant T-currents, we used both transiently transfected and stably expressed Ca V 3.1 or Ca V 3.2 channels in human embryonic kidney (HEK-293) cells as reported previously (Joksovic et al., 2006) . HEK-293 cells (CRL-1573; American Type Culture Collection, Manassas, VA) were grown in Dulbecco's modified Eagle's medium/F-12 media (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum, penicillin G (100 mg/ml), and streptomycin (0.1 mg/ml). Transiently transfected cell lines were made using cDNA encoding human Ca V 3.1 or Ca V 3.2, and a plasmid encoding the CD8 antigen. Cells were then incubated with polystyrene microbeads coated with CD8 antibody (Dynabeads M-450 CD8; Dynal GmbH, Hamburg, Germany). After ϳ48 h, cells with microbeads bound were selected for electrophysiology.
In Vitro Anesthetic Preparation. Isoflurane (Abbott Laboratories, Abbott Park, IL) was prepared as a saturated stock solution incubated overnight in a tightly sealed glass bottle (40 ml of Iso and 60 ml of external solution) and freshly diluted to appropriate concentrations at the time of experiments, using only the upper aqueous layer. To quantify the actual anesthetic concentrations in solutions, we had analyzed previously samples of identically prepared saturated stock solutions and aliquots in a gas chromatograph calibrated with appropriate volatile anesthetic standards (Todorovic and Lingle, 1998; Joksovic et al., 2005b) . By measuring actual concentrations, we found less than 10% loss if the solution was used within 30 min after preparation. Test solutions were maintained in tightly sealed, all-glass syringes.
Electrophysiology. All recordings were made using standard whole-cell techniques. Electrodes were fabricated from borosilicate microcapillary tubes (Drummond Scientific, Broomall, PA) and firepolished to final resistances of 2 to 3 M⍀. Voltage commands and digitization of membrane voltages and currents were done with Clampex 9.2 of the pClamp software package (Molecular Devices, Sunnyvale, CA), running on an IBM-compatible computer. Membrane voltages and currents were recorded with an Axopatch 200B patch-clamp amplifier (Molecular Devices). Data were analyzed using Clampfit 9.2 (Molecular Devices) and Origin 7.0 (OriginLab Corp, Northampton, MA). Currents were filtered at 2 kHz. Series resistance (R s ) and membrane capacitance (C m ) values were taken directly from readings on the amplifier after electronic subtraction of the capacitative transients. We compensated for 50 to 80% of R s . Cells were held (V h ) at Ϫ90 mV and depolarized to a test potential (V t ) of Ϫ30 mV every 10 to 20 s to evoke inward Ba 2ϩ currents unless otherwise noted. In most experiments, a P/N protocol was used for online leak subtraction.
Multiple independently controlled glass syringes served as reservoirs for a gravity-driven local perfusion system, in which manually controlled valves allowed for switching between syringes. Solution exchange was accomplished by constant suction through a glass capillary tube at the opposite end of the recording dish. All drugs were prepared as stock solutions and freshly diluted to appropriate concentrations at the time of experiments. The external recording solution used to isolate Ba 2ϩ currents in HEK-293 cells contained 2 to 10 mM BaCl 2 , 152 mM tetraethylammonium chloride, and 10 mM HEPES, pH adjusted to 7.4 with tetraethylammonium-OH. The internal solution contained 110 mM cesium-methane sulfonate, 14 mM phosphocreatine, 40 mM HEPES, 2 mM Mg-ATP, and 0.1 mM Na-GTP, adjusted to pH 7.2 with KOH.
Data Analysis and Statistical Procedures. Peak currents and exponential fits to currents were calculated using Clampfit, whereas curve-fitting was performed using Origin 7 software. For general statistical evaluations, we used one-and two-way analyses of variance with values Ͻ0.05 judged to be statistically significant and paired or unpaired Student's t tests as appropriate.
Analysis of Current Blockade. The percentage reduction in peak T-current at a given Iso concentration was used to generate concentration-response curves. For each such curve, all points are averages of multiple determinations obtained from at least three different cells. In most of the cells, we tested at least two different concentrations of Iso. On all plots, vertical bars indicate Ϯ S.E.M. Mean values on concentration-response curves were fit to the following equation:
nH ), where PB max is the maximal percent block of peak T-current, IC 50 is the concentration that produces 50% of maximal inhibition, and n H is the apparent Hill coefficient for blockade. Fitted values are typically reported with 95% linear confidence limits.
Analysis of Current. The voltage dependence of steady-state activation was described with a single Boltzmann distribution:
, where G max is the maximal estimated conductance, V 50 is the half-maximal voltage, and k (units of millivolts) represents the voltage dependence of the distribution. The voltage-dependence of steady-state inactivation was described with a single Boltzmann distribution:
, where I max is the maximal current, V 50 is the half-maximal The time courses of macroscopic current inactivation and deactivation of tail currents were fitted using a single exponential equation: f(t) ϭ A 1 exp(Ϫt/ 1 ), yielding one time constant ( 1 ) and its amplitude (A 1 ). For fitting the time course of recovery from inactivation, a double exponential function was used, yielding two time constants ( 1 and 2 ) and their corresponding amplitudes (A 1 and A 2 ). For all steady-state inactivation curves, fitted values typically were reported with 95% linear confidence limits.
Behavioral Studies. Adult mice of either gender were used for all behavioral studies. Ca V 3.2 knockout mice [Ca V 3.2(Ϫ/Ϫ)] and their age-matched WT litter mates [Ca V 3.2(ϩ/ϩ)] were studied at 16 to 60 weeks of age. The initial breeding pair for our colony of Ca V 3.2(Ϫ/Ϫ) mice was obtained through the courtesy of Dr. Kevin Campbell (University of Iowa, Iowa City, IA). These mice were repeatedly backcrossed for at least six generations against wild-type (C57BL/ 65J) mice. Animals were genotyped using tail biopsy. All behavioral experiments were performed in a blinded manner. Mutant mice were normal in appearance, weight, and overt behavior. They demonstrated a brisk righting reflex and in a previous study showed no differences in motor abilities under control conditions (Choi et al., 2007) .
To compare anesthetic phenotypes accurately, we used procedures similar to those used recently to characterize Ca V 3.1-deficient mice for behavioral testing of anesthetic endpoints (Petrenko et al., 2007) . Animals were tested individually in a small Plexiglas chamber that was connected to an anesthetic vaporizer via a plastic nose cone made from latex glove. Iso was vaporized in 2 to 6 l/min oxygen. Anesthetic concentration was constantly monitored by an infrared gas analyzer (Datex-Engtstrom, Helsinki, Finland). Each concentration of Iso was maintained for a minimum equilibration period of 20 min. In all behavioral experiments, we recorded rectal temperatures (Oakton Instruments, Vernon Hills, IL) before and after each measurement. Body temperature was actively maintained between 36°a nd 38°C with an electric heat mat placed beneath the testing chamber.
We used loss of righting reflex (LORR) as a measure of anestheticinduced hypnosis. An initial concentration of 0.6% atm Iso was administered and allowed to equilibrate. The chamber was then rotated to gently place the mouse on its back, and the mouse was monitored for 3 consecutive tries, the first lasting 45 s, and the second two lasting 1 min each. LORR onset was considered to be a failure of the animal to right itself on all three tries but disregarded if the animal was able to right itself on any of the three. None of the animals demonstrated LORR at this concentration. Iso concentration was then increased by 0.1% atm for another equilibration period, and the response was tested again. LORR ED 50 (50% concentration for LORR) was calculated by averaging the two concentrations at which the mouse either retained or lost its righting reflex.
Time to LORR (TTLORR) was used as another measure of Iso hypnosis. We measured the ability of mice to right themselves within 15 s after being placed on their backs. Mice were evaluated at 30-s intervals after beginning exposure to 1.0, 1.4, or 2.0% Iso. The average time to first LORR (over three trials) was considered time to LORR. We also determined time to LORR for the intravenous anesthetic 2,6 diisopropylphenol (propofol; AstraZeneca Pharmaceuticals, Wilmington, DE), which was given intraperitoneally (180 mg/ kg) after a negative aspiration test. The TTLORR after propofol injections was assessed by using two consecutive 15-s periods every minute or when deemed necessary by observation. Failure of the mouse to right itself in both constituted the onset of the LORR.
The immobilizing properties of Iso or halothane (Hal) were examined using tail-clamp experiments to determine MAC. The volatile anesthetics were delivered to the mice through a modified thumb portion of a latex glove. A latex glove was used to ensure that the mice were being exposed to a constant concentration of volatile anesthetic. The glove tip was connected to a vaporizer and an oxygen source with a flow of 2 l/min. For Iso, the concentration started at 0.9% for KO mice and 1.1% for the control mice with incremental increases of 0.1%. This experiment was repeated with Hal starting at an initial concentration of 0.8% for KO mice and 1.0% for control mice with incremental increases of 0.1%. These values were established after initial testing of both knockouts and controls. The mice were equilibrated at each concentration of anesthetic for at least 30 min (Iso) or 40 min (Hal). A plastic clamp was then used to clamp the proximal third of the mouse's tail. If a response was elicited, the concentration of anesthetic was subsequently increased by 0.1%. If there was no response, a metal artery clamp was clamped on the proximal third of the tail on its first notch. Then, if a response was elicited, the concentration was increased. However, if there was still no response, then this concentration was recorded as the value at which the mouse had no response. This is because the metal artery clamp is a suprathreshold stimulus. MAC was calculated by averaging the two concentrations at which the mouse either retained or lost the movement response. If the same mice were used for LORR and MAC studies, at least 1 week was allowed between each treatment for recovery. For behavioral studies, statistical analysis was performed using Student's t test or Mann-Whitney rank sum test.
Animals. Ethical approval was obtained for all experimental protocols from the University of Virginia Animal Care and Use Committee (Charlottesville, VA). All experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals adopted by the U.S. National Institutes of Health. Every effort was made to minimize animal suffering and the number of animals used.
Results

State-Dependent Inhibition of T-Current Variants by Isoflurane.
We first characterized the effects of 300 and 600 M Iso on Ca V 3.1 and Ca V 3.2 currents in the form of a current-voltage (I-V) series. Most notable in Fig. 1, A and B , are the concentration-dependent and almost complete inhibition of current amplitude over the wide range of test potentials for both isoforms. When normalized peak current was converted to conductance, it is noticeable that 300 M Iso produced a significant (ϳ4 mV) depolarizing shift in the conductance curves of Ca V 3.2, although it had a minimal effect on Ca V 3.1 (Fig. 1C) . Based on these initial results, we further explored the differential effects of Iso on these two key isoforms of human T-channels. We chose to perform our other studies using 300 M Iso, a clinically relevant concentration for in vitro studies (MAC, ϳ320 M) (Franks and Lieb, 1994) .
Inactivation is one of the main features that distinguishes T-currents from high voltage-activated currents. Inactivation of T-currents is normally complete with voltage-clamp commands that are subthreshold for high-voltage activation. It is noteworthy that alteration of T-current inactivation kinetics by anesthetic agents can result in very different operational ranges of membrane potential in which action potential firing can be generated. Thus, we analyzed macroscopic inactivation kinetics of current waveforms fitted with a single exponential function ( Fig. 2A) . Iso (300 M) minimally affected macroscopic current inactivation in both isoforms as evidenced by largely overlapping points before (open symbols) and after Iso application (filled symbols). Next, we assessed the influence of the same concentration of Iso on macroscopic current activation by measuring 10 to 90% rise time. Figure  2B shows that Iso at 300 M has very little effect on 10 to 90% rise times for either Ca V 3.1 or Ca V 3.2. Solid curves denote single exponential equation fits. However, 600 M Iso significantly increased the rate of macroscopic current activation and inactivation (data not shown). On average, for Ca V 3.1 constructs, 10 to 90% rise time (V h Ϫ90 mV; V t Ϫ30 mV) was in control conditions 4.3 Ϯ 0.3 ms and during Iso application, 3.0 Ϯ 0.4 ms (n ϭ 8, p Ͻ 0.01), whereas for Ca V 3.2 constructs, it was 4.7 Ϯ 0.4 ms in control (n ϭ 6) and 3.4 Ϯ 0.1 ms with Iso (n ϭ 9, p Ͻ 0.05). Likewise, average inactivation time constants for Ca V 3.1 constructs in these cells (V h Ϫ90 mV; V t Ϫ30 mV) was in control conditions 15.3 Ϯ 1.2 ms and during Iso application, 10.6 Ϯ 0.9 ms (p Ͻ 0.001), whereas for Ca V 3.2 constructs, it was 21.2 Ϯ 0.9 ms in control and 12.2 Ϯ 0.9 ms with Iso (p Ͻ 0.001).
T-channels deactivate (close) much more slowly than other voltage-gated Ca 2ϩ channels. That is, they take more time to return from the open state to the resting state. This is evidenced by a slowly relaxing tail current at the end of short- Fig. 1 . A, families of representative traces from current-voltage series traces from HEK cells transfected with Ca V 3.1 (left) and Ca V 3.2 (right) constructs. Cells were held at Ϫ90 mV, with steps ranging from Ϫ80 to Ϫ20 mV before (control, top traces) and during application of 300 M Iso (bottom traces). Traces are shown in 10-mV increments for clarity. B, average normalized current-voltage relationships in the same cells (n ϭ 6 -8) before (E) and during application of 300 M Iso (F) and 600 M Iso (OE) for Ca V 3.1 (left) and Ca V 3.2 (right) constructs. Note that Iso blocked inward currents of both isoforms over the wide range of test potentials. Vertical lines represent S.E.M. and are visible only if larger than symbols. C, apparent peak conductance values calculated from I-V curves in B plotted against command potentials. The extrapolated reversal potential (E r ) was taken to be ϩ55 mV activating test pulse. This transition determines the mean open time and the bursting behavior of the channel. Hence, to study the possible effects of Iso on the voltage-dependence of deactivation kinetics, tail currents were recorded over a sufficiently negative range of membrane potentials (e.g., Ϫ160 to Ϫ70 mV in 10-mV increments), after an 8-ms depolarizing step to Ϫ30 mV (Todorovic and Lingle, 1998) . We determined the time constant of current decay using a single exponential fit of the time course of tail currents before and during application of 300 M Iso in the same cells (Fig. 3A) . As shown in Fig. 3B , 300 M Iso markedly speeds deactivation time constants in both Ca V 3.1 and Ca V 3.2 isoforms over a wide range of membrane potentials. These changes were significant at all voltages shown (paired t test, p Ͻ 0.05) but are most impressive at physiologically relevant voltages (e.g., 2-3-fold change at Ϫ70 mV). This is important because deactivation can become physiologically significant after brief depolarizations that activate T-channels. The driving force for ion permeation at deactivation potentials is large so that significant Ca 2ϩ entry can occur until the channels are completely deactivated. Thus, T-currents may serve to promote Ca 2ϩ influx during the repolarization phase of action potentials in neurons (McCobb and Beam, 1991) . Furthermore, by changing the time constant and/or voltage-dependence of T-current deactivation, anesthetic agents can modulate neuronal excitability.
Binding to inactivated states is an important property of drugs that modulate ion channels because it can provide selectivity to their action. Transitions from closed to inactivated states can be measured using long prepulses at different potentials, producing what are commonly referred to as the steady-state inactivation curves. Steady-state inactivation curves were assessed using a standard double-pulse protocol with 3.6-s long prepulses to variable voltages (from Ϫ110 to Ϫ45 mV) and test potentials to Ϫ40 mV. Figure 4A shows representative traces of currents in HEK cells transfected with Ca V 3.1 (left) and Ca V 3.2 (right) constructs before (top) and after application of 300 M Iso (bottom). Iso (60, 150 and 300 M) caused concentration-dependent hyperpolarizing shifts of steady-state relationships even after exposure to as little as 60 M Iso (Fig. 4B, top, left) . Applications of 300 M Iso resulted in approximately 6-mV leftward shift on Ca V 3.1 and approximately 4-mV shift on Ca V 3.2 (Fig. 4B,  bottom) . All changes were statistically significant (p Ͻ 0.05), except for the effects of 60 M Iso on Ca V 3.2 (paired t test, p Ͼ 0.05).
These data suggest that Iso binds to and stabilizes inactive states of the channel and thus is a more potent blocker at depolarized membrane potentials. To further confirm this notion, we evaluated concentration-response curves for Iso inhibition of T-currents at different holding potentials. Cells were exposed to the same concentrations of Iso while held at membrane potentials of Ϫ100 and Ϫ65 mV. Representative traces (Fig. 5, A and B) illustrate a 2-to 3-fold greater block of peak Ca V 3.1 and Ca V 3.2 current when cells were held at Ϫ65 mV rather than Ϫ100 mV. Figure 5C shows the average Fig. 2 . A, rates of macroscopic current inactivation (n ϭ 6 -8, error bars represent S.E.M.) from the same cells used to generate current-voltage curves depicted in Fig. 1 in control (open symbols) and during application of 300 M Iso (filled symbols) for Ca V 3.1 (left) and Ca V 3.2 (right). All points represent averages from multiple cells where inactivation was obtained at indicated potentials by fitting the decaying portion of the current with a single exponential function. B, all points represent averages of 10 to 90 rise time of the same cells. Rise time was measured as time between 10 and 90% of peak current. Solid lines are fits by a single exponential function. Calculated values were as follows: Ca V 3.1 control, 11.0 Ϯ 0.5; Ca V 3.1 Iso, 11.5 Ϯ 0.4; Ca V 3.2 control, 13.5 Ϯ 0.4; Ca V 3.2 Iso, 15.8 Ϯ 0.6 (n ϭ 6 -8, error bars represent S.E.M.). concentration-response data from multiple cells. Depolarizing the cells decreased the IC 50 value of Iso approximately 2-fold for Ca V 3.1 (left) and 2.7-fold for Ca V 3.2 (right). As result, the difference in the degree of inhibition of peak current at 300 M Iso is significant for both isoforms at different holding potentials (t test, p Ͻ 0.05).
T-channels can recover from inactivation during sufficiently long hyperpolarizations of the neuronal membrane caused by inhibitory synaptic potentials in CNS (PerezReyes, 2003) or the effects of neuromodulators like serotonin in peripheral sensory neurons (Nelson et al., 2005) . Rates of recovery can drastically influence firing properties of cells that express T-channels. Thus, we determined the effect of Iso on recovery from inactivation (deinactivation) of T-channels using our standard double-pulse protocol with variable duration prepulse (Fig. 6A) . As expected from the effects of Iso on steady-state inactivation (Fig. 4) , recovery from inactivation was slowed in both Ca V 3.1 and Ca V 3.2 after exposure to 300 M Iso (Fig. 6, A and B) . Average data in Fig. 6B indicate that, when fitted with a double exponential curve, Iso produced a 1.5-fold increase in both isoforms of the slow component of the time constant and in Ca V 3.1's fast component. It is interesting that Iso caused a 3-fold increase of Ca V 3.2's fast component.
To further explore the mechanism of Iso inhibition of these channels, we investigated the tonic blockade of the channel by using a protocol that allowed the assessment of Iso interaction with resting states of the channel. First, we obtained baseline measurements of peak current amplitude when cells were repeatedly depolarized to Ϫ30 mV every 10 s, then applied 300 M Iso to cells for 2 min with no stimulation, and finally measured the amplitude of the first current wave form after resuming stimulation after Iso application (Fig. 7, A  and B) . A summary histogram comparing current amplitudes after the first depolarizing pulse with normal inhibition shows that there is a similar degree of block of the channel in Fig. 3 . Isoflurane (300 M) increases the speed of current deactivation in both Ca V 3.1 (left) and Ca V 3.2 (right) constructs. A, normalized traces of tail currents from representative cells at deactivating test potentials of Ϫ70 mV for Iso (top traces) and control (bottom traces). B, deactivating tail currents in control (open symbols) and during application of 300 M Iso (filled symbols) were fit with a single exponential function, and the resulting values are plotted (n ϭ 5, error bars represent S.E.M.). All points are statistically significant (p Ͻ 0.05). Insert at the bottom depicts the protocol used in these experiments, where cells were held at Ϫ90 mV, then subjected to a 8-ms long activating pulse to Ϫ30 mV, and followed by variable deactivating steps from Ϫ160 to Ϫ70 mV.
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at ASPET Journals on June 21, 2017 molpharm.aspetjournals.org both isoforms: ϳ57% block of the resting (previously nonstimulated) channels versus ϳ50% of the constantly stimulated channels. Thus, it seems that Iso binds preferentially to resting states over open and inactive channel states.
Some blockers more effectively inhibit currents when channels are more frequently depolarized, presumably due to greater access to high-affinity binding states. As shown in Fig.  8A , 300 M Iso blocked ϳ50% of Ca V 3.1 current when cells were stimulated every 6 s. When the stimulation frequency was reduced to once every 60s, only ϳ40% inhibition was observed (p Ͼ 0.05). A greater difference is seen in Ca V 3.2 as depicted by representative current traces and time course of current inhibition (Fig. 8B) . Histograms shown in Fig. 8C indicate that the same concentration of Iso inhibits ϳ70% of Ca V 3.2 current when stimulated every 6 s and only ϳ50% when stimulated every 60 s (paired t test, p Ͻ 0.05). This use-dependence of inhibition indicates that Iso also binds to channel states entered upon membrane depolarization.
Mice Lacking Ca V 3.2 Have Altered Sensitivity to Volatile Anesthetics. A complete anesthetic state involves loss of consciousness (hypnosis), movement (immobilization), pain sensation (analgesia), and recollection of the event (amnesia). New theories propose that multiple endpoints of anesthesia are mediated by multiple relevant cellular mechanisms (Urban, 2002; Rudolph and Antkowiak, 2004) . According to this multisite hypothesis, the importance of a particular molecular target depends on the specific anesthetic and the specific endpoint in consideration. In agreement with this view, recent genetic studies with knockout mice of various ion channels have demonstrated variable, often small, alterations only in certain endpoints of anesthetic states (Rudolph and Antkowiak, 2004; Franks, 2008) . Calcium current inhibition may be important to anesthetic action in either of two ways. First, it is possible that selective inhibition of particular Ca 2ϩ channel subtypes in CNS neurons may be central to the effects of some Fig. 4 . Steady-state inactivation in human Ca V 3.1 (left) and Ca V 3.2 Ca 2ϩ (right) channels. A, representative current traces are shown in control (top) and during application of 300 M Iso (bottom) every 10 mV for clarity. Voltage protocol is depicted at the bottom: currents were measured using 3.6-s long inactivating pulses (Ϫ110 to Ϫ45 mV), followed by a brief activating step to Ϫ40 mV. B, average data from similar experiments with different concentrations of Iso were fitted with Boltzmann equation ( channels versus other potential targets may contribute to the diversity of effects produced by these agents. Thus, we tested the anesthetic sensitivity of mice lacking Ca V 3.2 channels and compared the results with findings reported recently regarding the Ca V 3.1 isoform (Petrenko et al., 2007) .
First we examined the immobilizing effects of Iso in mutant and wild-type litter mate mice using tail-clamp tests for the determination of MAC. Figure 9A shows that Ca V 3.2 knockout mice have approximately 15% decreased MAC requirements for Iso and Hal (Mann-Whitney rank sum test, p Ͻ 0.001). In contrast, KO mice show no statistical difference from wild-type litter mates for the concentration of Iso needed to reach LORR (Fig. 9B) . However, mutant mice have a considerably slower induction of anesthesia as manifested by approximately 60% longer times for loss of righting reflex (TTLORR) at 1.0 and 1.4% (p Ͻ 0.05, t test) but not with 2% Iso (Fig. 9C) . It seems that slower anesthetic induction was isoflurane-specific because we did not observe difference in TTLORR between the wild-type and mutant mice after intraperitoneal injections of a prototypical intravenous anesthetic, propofol, at 180 mg/kg (n ϭ 13 in each group, p Ͼ 0.05, Mann-Whitney rank sum test; data not shown).
Discussion
Biophysical Mechanisms of T-Channel Inhibition by
Isoflurane. Recent studies have indicated that among other native voltage-gated calcium channels, T-channels are particularly sensitive to inhibition by volatile anesthetics (Takenoshita and Steinbach, 1991; Herrington and Lingle, 1992; Study, 1994; McDowell et al., 1996; Todorovic and Lingle, 1998; Ries and Puil, 1999; Joksovic et al., 2005a,b) . This study describes the inhibition of cloned human Ca V 3.1 and Ca V 3.2 T-type channels by a commonly used volatile anesthetic, isoflurane. Previous pharmacological studies have demonstrated a similar sensitivity of recombinant rat Ca V 3.1 (Todorovic et al., 2000) and rat Ca V 3.3 (Joksovic et al., 2005a) to this anesthetic but have not presented an in-depth com- Fig. 5 . Voltage-dependent inhibition of human T-channel isoforms by isoflurane. A, representative traces of inward currents in the absence and presence of 300 M Iso recorded from Ca V 3.1 in response to voltage steps to V t Ϫ30 mV from holding potentials (V h ) of Ϫ65 (left) or Ϫ100 mV (right) applied every 10 s. In this cell, Iso inhibited approximately 50% of Ca V 3.1 current at V h Ϫ100 mV and more than 70% at V h Ϫ65 mV. B, A similar effect is evident for Ca V 3.2 because Iso inhibited (in the same cell) only approximately 25% current at V h Ϫ100 mV and approximately 66% at V h Ϫ65 mV. Voltage protocols are depicted at the bottom shown in A and B. C, percentage of inhibition of peak current is plotted against drug concentration. IC 50 values from fitted data (solid lines) using a Hill equation were the following: Ca V 3.1 at V h Ϫ65 mV, 166 Ϯ 20 M; slope, 1.2 Ϯ 0.2; Ca V 3.1 at V h Ϫ100 mV, 363 Ϯ 13 M; slope, 1.3 Ϯ 0.1; Ca V 3.2 at V h Ϫ65 mV, 172 Ϯ 43 M; slope, 1.1 Ϯ 0.3; Ca V 3.2 at V h Ϫ100 mV, 464 Ϯ 85 M; slope, 1.9 Ϯ 0.7. Number of cells recorded for each point is indicated on the graph. Error bars indicate S.E.M.
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at ASPET Journals on June 21, 2017 molpharm.aspetjournals.org parison between isoforms. In this article, we did not examine Ca V 3.3, choosing to focus on the two more kinetically similar but differentially tissue-expressed isoforms. For greatest relevance to human application, we performed all experiments using clinically pertinent anesthetic concentrations and used human isoforms of recombinant channels.
Our results strongly suggest that Iso inhibition of Ca V 3.1 and Ca V 3.2 T-currents occur primarily by interaction with resting channel states because we observed significant tonic channel inhibition. However, functionally important statedependent features of Iso inhibition of T-currents occur via stabilization of inactive channel states. This is seen in hyperpolarizing shifts in steady-state inactivation curves, greater potency of inhibition at more depolarized holding potentials, and slowing of recovery from inactivation. Evidence also points to Iso binding to open channels. Iso inhibited gating of Ca V 3.2 as evidenced by a depolarizing shift in channel activation curves in I-V relationships. Channel deactivation determines channel open time and bursting behavior. Thus, the observation that Iso allows both Ca V 3.1 and Ca V 3.2 channels to close more rapidly suggests an interaction with activation gate closure after repolarization. In addition, Iso inhibition of Ca V 3.2 Tcurrent increases with more frequent channel openings. This use-dependent block provides additional evidence that the Iso molecule visits open channel states. Exact molecular determinants of such complex interactions of Iso with T-channel are currently not known, but further examination of T-channel kinetics in the presence of anesthetics could provide more details on the channel states and structures that Iso is able to affect. This could be accomplished through single-channel studies and more extensive molecular mutagenesis studies.
It is noteworthy that we identified several biophysical features of channel inhibition that may have a significant impact on active membrane firing that was observed previously with volatile anesthetic-induced inhibition of low-threshold calcium spikes in functional current-clamp recordings in intact thalamic slices (Ries and Puil, 1999; Joksovic et al., 2005b) . For example, both voltage-and use-dependent inhibition, together with speeding of channel closure, will probably decrease the amount of calcium ions passing though the channel during action potentials. This in turn may profoundly affect the T-channel-dependent cellular excitability of these cells. It is important to mention that we and others have observed previously both voltage-dependent (Ries and Puil, 1999; Camara et al., 2001; Joksovic et al., 2005a) and voltage-independent (Takenoshita and Steinbach, 1991; Joksovic et al., 2005a) inhibition of different native T-currents by volatile anesthetics. It is not clear whether these inconsistencies are related to difference in recombinant versus native channels, different subunit composition, and/or different splice variants of T-channels present in native tissues. The last explanation seems plausible because all three T-channel isoforms may undergo extensive alternative splicing (Perez-Reyes, 2006) .
Functional Considerations of T-Channel Inhibition by Isoflurane. T-channels are new arrivals in the field of anesthesia research, but the part they play in pain transmission and sleep pathway make them interesting targets for further exploration. Knockout (Choi et al., 2007) and knockdown studies (Bourinet et al., 2005) have firmly established a prominent role for T-channels in DRG in amplifying nociceptive signals in the periphery and possible contributors to the development of central sensitization in the dorsal horn (Ikeda et al., 2003) . Based on these observations, it is not surprising that anesthetic agents that inhibit T-channels, such as Iso, also often possess notable analgesic qualities. In agreement with this, we report decreases in MAC requirements for Iso in Ca V 3.2 KO mice probably resulting from the prominent role of these channels in pain signaling. In contrast, studies of Ca V 3.1 KO mice did not find any changes in MAC for Iso or other volatile anesthetics (Petrenko et al., 2007) . Although both Ca V 3.1 and Ca V 3.2 isoforms are simi- larly inhibited by Iso, as shown in this study, and their mRNA transcripts are expressed in DRG and dorsal horn of the spinal cord (Talley et al., 1999) , it seems that Ca V 3.2 is a more important contributor to anesthetic-induced analgesia. Our results strongly suggest that any future pharmaceutical developments of drugs that selectively inhibit Ca V 3.2 T-channels would be useful adjuvants for general anesthesia because they would reduce MAC.
We also found that genetic elimination of Ca V 3.2 leads to a marked delay of anesthetic induction with Iso. It is unlikely that this results from general depressant actions of Iso on the cardiovascular system because this effect was present only with lower concentrations of anesthetic. Thus, a specific role of Ca V 3.2 in neural pathways that mediate hypnotic/sedative effects of anesthesia is more likely. Although the role of Ca V 3.2 isoform in sleep is not established, Ca V 3.1 knockout mice also show slower anesthetic induction (Petrenko et al., 2007) and have an abnormal natural sleep phenotype, probably resulting from the lack of T-channels and underlying burst firing in the thalamic relay neurons (Lee et al., 2004; Anderson et al., 2005) . Furthermore, recent studies implicate the thalamus as a possible central site for the hypnotic/ Fig. 8 . Use-dependent block of Ca V 3.1 and Ca V 3.2 currents by isoflurane. A. traces from representative cells at V h Ϫ90 mV in control conditions (open symbol) and before and during application of 300 M Iso. Cells were stimulated with a depolarizing pulse to V t Ϫ30 mV either every 6 s (black filled symbol) or every 60 s (gray filled symbol). B, time courses of Iso application (300 M) in the same cells depicted in A. Horizontal bars indicate duration of application of Iso. Note that Iso inhibited more potently inhibits Ca V 3.2 currents with more frequent stimulation, whereas there is little difference in Ca V 3.1 current regardless of frequency of stimulation. C, pooled data (n ϭ 7-8) show greater current inhibition of Ca V 3.2 but not Ca V 3.1 with Iso with more frequent membrane depolarization. Percentage block: Ca V 3.1 every 6 s, 48.9 Ϯ 2.4; Ca V 3.1 every 60 s, 40.1 Ϯ 4.4; Ca V 3.2 every 6 s, 67.2 Ϯ 1.9; Ca V 3.2 every 60 s, 48.2 Ϯ 2.3. ‫,ء‬ significant difference, p Ͻ 0.005 with Student's t test. sedative effects of many anesthetic agents. The thalamus is a major "gateway" of corticothalamocortical functional connections and expresses abundant Ca V 3 isoforms on neuronal somas and dendrites where these channels can shape neuronal excitability and synaptic integration, respectively. Functional imaging studies in both humans and animals have led to the theory that direct and indirect depression of thalamocortical neurons may provide a convergence point for neural pathways of anesthetic action, leading to a sleep-like state (Alkire et al., 2000) . Mutually interconnected cortical, thalamic reticular neurons, and thalamic relay neurons exhibit tonic and burst firing that represent different functional modes (McCormick and Bal, 1997; Steriade, 2005) . During tonic firing, which predominates during awake states, there is a faithful transfer of sensory information to cortical neurons. In contrast, during slow oscillations with a burst firing pattern, which critically depends on functional T-channels, there is an impairment of sensory transfer and transition to sleep states. It is well established that these slow oscillations underlie ␦ rhythms on electroencephalogram generated by the thalamocortical projection neurons and are very prominent during anesthesia (Franks, 2008) and in slow wave sleep (McCormick and Bal, 1997; Steriade, 2005) . However, it is important to notice that Iso affects other ion channels in thalamocortical sensory pathways such as GABA A and potassium leak (I LEAK ) currents (Ries and Puil, 1999; Franks, 2008) , and the overall effect of this anesthetic probably results from the interplay between all conductances that finely tune the inflow of sensory information into the thalamus.
Our findings of delayed anesthetic induction in Ca V 3.2 and similarly in Ca V 3.1 knockout mice (Petrenko et al., 2007) in vivo argue that at low and moderate levels of anesthesia with Iso (1.0-1.4% in vivo, or roughly 200-250 M in vitro), Tchannels are still functionally active and capable of producing burst firing in thalamocortical circuitries. This is probably because at subanesthetic concentrations, activation of . LORR in WT mice was 0.78 Ϯ 0.03% and in KO mice, 0.79 Ϯ 0.04% (n.s., not significant; p Ͼ 0.05 by t test). Number of experimental animals in each group is indicated in the bars. C, slower anesthetic induction with Iso in Ca V 3.2 KO mice (filled bars) than in wildtype litter mates (open bars) is indicated with longer normalized TTLORR at 1.0 and 1.4% inhaled gas but not at 2.0%. In each group, 12 animals were tested on different days with at least 1 week between experiments. Compared with wildtype group, KO mice had TTLOR increased by 60.0 Ϯ 15.0% (1.0% Iso), 56.3 Ϯ 15.0% (1.4% Iso), and by 8.8 Ϯ 18.8% (2.0% Iso). ‫,ء‬ significance at p Ͻ 0.05; n.s., not significant by t test.
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at ASPET Journals on June 21, 2017 molpharm.aspetjournals.org GABA A receptors and I LEAK would sufficiently hyperpolarize neurons, which would in turn deinactivate T-channels and relieve the state-dependent inhibition of thalamic T-channels by Iso. During deeper levels of anesthesia (e.g., 2% in vivo, roughly 400 M in vitro), Iso causes a block of sensory information transfer between the thalamus and the cortex, with electroencephalogram patterns changing to a characteristic burst suppression mode and finally to an isoelectric line (Franks, 2008) . This effect would be consistent with a strong direct inhibition of T-channels and more profound hyperpolarization of neuronal membrane. Both of these would lead to eventual cessation of the thalamocortical rhythmicity. Consistent with this, we did not find a difference in the speed of anesthetic induction with 2% Iso between Ca V 3.2 knockout mice and wild-type litter mates. In conclusion, the results of the present study support the idea that inhibition of neuronal T-channels in pain and sleep pathways by volatile anesthetics may contribute to useful clinical properties of these agents such as analgesia, immobility, and sedation/hypnosis.
